You are here

immunotherapy

Novartis, Bayer, Longwood back genomics startup to speed search for immunotherapy targets

Endpoints

Thu, 11/21/19 - 10:21 am

immuno-oncology

Bone Tumors Stop Immunotherapy Working For Prostate Cancer

Forbes

Sun, 11/17/19 - 08:53 pm

prostate cancer

Editas and Celgene sub Juno are tackling hottest immunotherapy cells

Endpoints

Tue, 11/12/19 - 08:07 pm

Editas Medicine

Juno Therapeutics

Working on the Next Generation of Immuno-Oncology Therapies

BioSpace

Fri, 10/25/19 - 10:42 am

immuno-oncology

Washington University School of Medicine

Verseau launches with $50m to develop first-in-class macrophage-targeted immunotherapies

Pharmaceutical Business Review

Mon, 10/21/19 - 04:37 pm

Verseau Therpeutics

Lilly cancer drug pipeline hit by trial setback

Biopharma Dive

Wed, 10/16/19 - 12:21 pm

pancreatic cancer

ARMO BioSciences

Pushing to Improve Immunotherapies, Arcellx Raises $85 Million in Series B

BioSpace

Thu, 10/3/19 - 10:13 pm

Moderna pens mRNA immunotherapy pact with Harvard

Fierce Biotech

Thu, 09/26/19 - 12:25 pm

Moderna Therapeutics

Tactiva Therapeutics — A Biotech Startup Focusing on the Future of Immunotherapy

Persimmon Development

Wed, 08/7/19 - 04:30 pm

Tactiva Therapeutics

In a small study, a cancer vaccine assist beats immunotherapy drugs alone

Stat

Mon, 07/15/19 - 10:03 am

cancer vaccines

Neon Therapeutics

metastatic non-small-cell lung cancer

metastatic bladder cancer

Are Natural Killer Cells the Next Big Thing in Immunotherapy?

Motley Fool

Mon, 07/8/19 - 09:51 am

NK immunotherapies

Provention’s Teplizumab Can Delay Onset of Type 1 Diabetes, Trial Results Show

BioSpace

Mon, 06/10/19 - 04:26 pm

clinical trials

type 1 diabetes

ASCO 2019: The Long Game, Targeted Pills, First-Ever Buzz & More

Xconomy

Wed, 06/5/19 - 10:43 am

Moderna Therapeutics

Nektar Therapeutics

Blueprint Medicines

The entrepreneur behind the cancer immunotherapy revolution

Stat

Mon, 04/29/19 - 09:39 am

Merck to buy immunotherapy developer Immune Design for $300 million

Reuters

Thu, 02/21/19 - 09:58 am

After Tesaro buy, GSK wades deeper into cancer unveiling big immunotherapy deal with Germany's Merck

Endpoints

Tue, 02/5/19 - 09:52 am

Five Things To Look Out For In Cancer Research In 2019

Forbes

Mon, 12/31/18 - 12:06 pm

Not So Fast With Immune Therapy For Breast Cancer

Forbes

Mon, 10/22/18 - 11:14 pm

CytoReason: Machine-Learning Findings Reveal New Information That Might Lead to Improved Immunotherapy for Refractory Melanoma Patients

CP Wire

Tue, 10/16/18 - 09:44 am

machine learning

CytoReason: Machine-Learning Findings Reveal New Information That Might Lead to Improved Immunotherapy for Refractory Melanoma Patients

Tue, 10/16/18 - 09:38 am

Pages